Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 6 Jan - 12 Feb 2021
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 luciferase KeratinoSens™ test method)
- Version / remarks:
- adopted in 2018
- Deviations:
- yes
- Remarks:
- no historical control data range provided
- GLP compliance:
- yes
- Type of study:
- ARE-Nrf2 luciferase KeratinoSens™ test method
Test material
- Reference substance name:
- Fatty acids, C6-18 (branched and linear) alkyl and hydrocarbons, C10-18, n-alkanes, branched alkanes, cycloalkanes, aromatics
- Molecular formula:
- not applicable due to UVCB substance
- IUPAC Name:
- Fatty acids, C6-18 (branched and linear) alkyl and hydrocarbons, C10-18, n-alkanes, branched alkanes, cycloalkanes, aromatics
- Test material form:
- liquid
Constituent 1
In vitro test system
- Details of test system:
- Keratinoses transgenic cell line [442D]
- Details on the study design:
- TEST METHOD:
The in vitro KeratinoSens™ assay enables the detection of the skin sensitising potential of a test item by analysing the activation of keratinocytes. This activation step represents the second molecular key event of the adverse outcome pathway, which is the induction of cyto-protective signaling pathways in keratinocytes in response to electrophilic test chemicals. The KeratinoSens™ assay addresses the effect on the antioxidant response element (ARE) Nrf2-dependent pathway in the transgenic KeratinoSens™ cell line, which is an immortalised adherent cell line derived from HaCaT human keratinocytes, stably transfected with a selectable plasmid containing the luciferase gene under the transcriptional control of the Anti-oxidant Response Element (ARE) from a gene that is known to be up-regulated by contact sensitisers. The Nrf2-dependent induction of this reporter gene is analysed following exposure to test chemicals. Luminescence detection in the cell lysate after 48 ± 2 h of exposure at 37.0 ± 1.0 °C indicates luciferase induction and allows the discrimination between skin sensitisers and non-sensitisers. The method was adapted to animal product-free conditions by the testing laboratory. The Foetal Calf Serum was replaced by Human Serum in the protocol following adaptation of the cells, and porcine trypsin was replaced by non-animal recombinant trypsin (Trypzean).
PREPARATION OF TEST SOLUTIONS
- Preparation of the positive controls : The positive control was 8, 16, 32, 64 and 128 µM cinnamic aldehyde, prepared in the solvent 1% ethanol in cell culture medium.
- Preparation of the solvent, vehicle and negative controls: The solvent control was 1% ethanol in cell culture medium. No justification was given for the choice of solvent control.
DOSE RANGE FINDING ASSAY:
The solubility of the test item in ethanol was confirmed up to 40 mg/mL. Subsequent dilution in cell culture medium gave a top concentration of 400 µg/mL, which was selected as the highest concentration in the main test.
APPLICATION OF THE TEST CHEMICAL AND CONTROL SUBSTANCES
- Number of replicates : 3
- Number of repetitions: 4 runs were performed. Each run consisted of 3 x 96-well plates for luminescence (n = 9 overall) and 2 x 96-well plates for MTT (n = 6 overall).
- Test chemical concentrations : 0.195, 0.391, 0.781,1.563, 3.125, 6.25, 12.5, 25, 50, 100, 200 and 400 µg/mL
- Application procedure : Per plate, for the test substance a single application of 12 concentrations of the test item was applied in cell culture medium (dilution factor of 2) with a final concentration of ethanol of 1%. For the positive and solvent control, per plate a single application of 5 concentrations of the positive control was applied in cell culture medium (dilution factor of 2) with a final concentration of ethanol of 1% and a single application of culture medium with 1% ethanol was applied as the negative control (6 wells per plate). One well per plate was left empty (no cells).
- Exposure time : 48 ± 2 h
- Study evaluation and decision criteria used: A test item is considered positive using the KeratinoSens prediction model if the following conditions are met in 2 of 3 repetitions:
1) The IMAX is ≥ 1.5-fold and statistically significantly different as compared to the solvent (negative) control (as determined by a two-tailed, unpaired Student’s T-test).
2) The cellular viability is higher than 70% at the lowest concentration with induction of luciferase activity ≥ 1.5-fold (i.e. at the EC1.5 determining concentration). Test items that only induce the gene activity at cytotoxic levels are not rated positive, as in the case for some non-sensitising skin irritants.
3) The EC1.5 value is < 1000 µM or < 200 µg/mL for test items with no defined MW.
4) There is an apparent overall dose-response for luciferase induction (or a biphasic response).
- Description on study acceptance criteria : Test results are acceptable if:
1) The positive control (cinnamic aldehyde) produces positive results, i.e. the luciferase gene induction produced by this control is above the threshold of 1.5 in at least one of the tested concentrations and this induction is statistically significant compared to the solvent (negative) control (p < 0.05).
2) The lMAX and the EC1.5 for cinnamic aldehyde is calculated and meet either or both of the following targets:
a) Average induction in the three replicates for cinnamic aldehyde at 32 µM is within the test facility's historical range (currently 1.6 and 3)
b) EC1.5 value for cinnamic aldehyde is within the test facility's historical range (currently 6 µM and 39 µM).
Note: At least one of these criteria must be met, otherwise the run is discarded unless there is sufficient reason not to do this as determined by the Study Director. If only one criterion is met, it is recommended to check the dose-response curve of cinnamic aldehyde in order to decide on acceptability.
3) CV% of blank values < 20%.
SEEDING AND INCUBATION
One day prior to testing cells were harvested, and seeded at a density of 10000 cells/well in basic medium in conventional 96-well plates. One plate was used for the luciferase activity measurements, and one parallel replicate was used for the MTT cell viability assay. The cells were incubated overnight in the incubator.
- Seeding conditions: passage number 17, seeding density 10,000 cells per well.
- Incubation conditions : 24 h after seeding, the test and control items were applied and plates were incubated at 37 °C, 5% CO2, ≥ 95% relative humidity for 48 ± 2 h.
LUCIFERASE ACTIVITY MEASUREMENTS
The luciferase activity induction was measured. No further details were given.
DATA EVALUATION
- Cytotoxicity assessment: An MTT assay was performed to measure the cellular viability. No further details were given.
- Other: Test facility's Form F0056: “KeratinoSens data processing” v.3 was used to analyse data. This form is a Microsoft Excel workbook, validated in-house (Mar 2019) containing formulae to process the raw data as described in SOP L0057. - Vehicle / solvent control:
- other: 1% ethanol in cell culture medium
- Positive control:
- cinnamic aldehyde [442D]
Results and discussion
- Positive control results:
- Cinnamic aldehyde was tested in a concentration range of 8 - 128 µM. The induction at 128 µM was ≥ 2-fold in 4 of 5 runs and showed a dose-dependent increase.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Group:
- test chemical
- Run / experiment:
- run/experiment 3
- Parameter:
- EC 1.5 [442D]
- Value:
- 12.04 µg/mL
- Cell viability:
- IC30 = 154.04 µg/mL, IC50 = 167.45 µg/mL
Imax = 4.719 at 100 µg/mL - Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Group:
- test chemical
- Run / experiment:
- other: run/experiment 4
- Parameter:
- EC 1.5 [442D]
- Value:
- 8.16 µg/mL
- Cell viability:
- IC30 = 253.91 µg/mL, IC50 = 295.65 µg/mL
Imax = 4.927 at 100 µg/mL - Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of skin sensitisation
- Outcome of the prediction model:
- positive [in vitro/in chemico]
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: no
DEMONSTRATION OF TECHNICAL PROFICIENCY:
The testing laboratory showed technical proficiency by validation in-house (studies 14XC004, 15XC001, 16XCO04) using the 10 proficiency chemicals and 11 reference chemicals described in TG 442D.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes, CV% < 20% for experiment 3 and 4 (mean CV%: 11.26%).
- Acceptance criteria met for positive control: 4 of 5 replicates showed > 1.5-fold induction in a dose-dependent manner. The average induction was 3.269 and therefore did not meet the acceptance criterium (1.6 - 3.0 at 32 µM). As the other acceptance criteria were met, the results were considered to be valid overall.
- Acceptance criteria met for variability between replicate measurements: Four experiments were performed because the variability (CV%) across the negative control wells in experiment 1 and 2 were greater than 20%. Therefore, experiment 1 (CV%: 52.69) and 2 (CV%: 35.71) were considered invalid and not used to determine the result for the test item. For experiment 3 and 4 the acceptance criteria were met (mean CV: 11.26%).
- Range of historical values if different from the ones specified in the test guideline: No historical control values were given in the study report. However, the results from the validation study were included.
Any other information on results incl. tables
Experiment 1
The test substance showed cytotoxicity, with an IC30 = 203.10 µg/mL and IC50 = 254.22 µg/mL. The Imax was 4.47 at 100 µg/mL and the EC1.5 was 15.06 µg/mL. However, the experiment was not considered to be valid as the variability across the negative control wells (CV%) was 52.69.
Experiment 2
The test substance showed cytotoxicity, with an IC30 = 287.63 µg/mL and IC50 = 317.19 µg/mL. The Imax was 2.83 at 100 µg/mL and the EC1.5 was 28.53 µg/mL. However, the experiment was not considered to be valid as the variability across the negative control wells (CV%) was 35.71.
Experiment 3
The Imax was 4.72 at 100 µg/mL and lead to an EC1.5 = 12.04 µg/mL. The test substance showed cytotoxicity, with an IC30 = 154.04 µg/mL and IC50 = 167.49 µg/mL. In this run the negative and positive control results met the acceptance criteria. As the results were considered to be valid, the overall outcome of the experiment was positive.
Experiment 4
The Imax was 4.72 at 100 µg/mL and the EC1.5 was 12.04 µg/mL. The test substance showed cytotoxicity, with an IC30 = 253.91 µg/mL and IC50 = 295.65 µg/mL. In this run, the negative and positive control results met the acceptance criteria. As the results were considered to be valid, the overall outcome of the experiment was positive.
Tables 1 - 4 with results are included in Attachment 1 under "Overall remarks, attachments".
Applicant's summary and conclusion
- Interpretation of results:
- other: skin sensitising potential based on the key event “inflammatory response in keratinocytes”
- Conclusions:
- There is regulatory acceptance in the EU for the application of the KeratinoSens™ test method to address key event 2, keratinocyte activation, in the skin sensitisation Adverse Outcome Pathway. Under the conditions of the test, the test substance induces keratinocyte activation. The result is not conclusive with respect to the non-classification or classification as skin sensitiser of the test substance and therefore further evaluation and/or data generation is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.